ENTITY
Johnson & Johnson

Johnson & Johnson (JNJ US)

251
Analysis
Health Care • United States
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
more
bullish•Sunningdale Tech
•12 Jul 2018 07:09

Sunningdale Tech (SUNN SP): Value...with a Catalyst - CONVICTION BUY

I am long Sunningdale Tech (SUNN SP).  Every time I've bought a stock after a panic selloff for non-fundamental reasons, I've typically done very...

Share
•01 Jul 2018 07:24

Kid's Stuff in Thai Equities

As mentioned earlier in The Greying of Thailand, Thailand's low population growth (0.8%) can be attributed to many reasons such as gender imbalance...

bullish•Nippon Shinyaku
•29 Jun 2018 20:21

Encouraging NS-065 Top-Line Data, However, Uptravi’s Global Ramp-Up Remains the Key

We reiterate our “Overweight” rating on the stock after reviewing our model post FY17 (YE Mar-18) earnings. Our rating is subject to Uptravi’s...

•31 May 2018 16:35

Sector Capsule: Skin Care in the US

Skin care posted healthy current value growth of 5% in 2017, to reach USD18.4 billion. The demand for efficacious and multifunctional skin care...

bullish•Astellas Pharma
•04 May 2018 22:39

Astellas FY17 Results and FY18e Guidance – No Major Surprise

Astellas Pharma Inc (4503 JP) FY17 results Xtandi (up 17% to ÂĄ295b) and mirabegron (up 28% to ÂĄ126b) ramp-up compensate for lackluster domestic...

x